CRISPR-X
Next generation gene editing - two decades after we learned how to read the human genome, we’re entering the era of gene writing enabled by CRISPR/Cas9.
We continue to push the boundaries of what’s possible with gene editing in the pursuit of new medicines.
We have a dedicated team called CRISPR-X that focuses on innovative research to develop next-generation editing and delivery modalities, such as all-RNA gene correction, whole gene insertion and non-viral delivery of DNA. These cutting-edge technologies could underlie the next wave of gene-editing therapies.
You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.